NeuroBo Pharmaceuticals, Inc. (NRBO) Financials
Stock symbol NRBO is outdated, potentially delisted? Maybe it is available on other exchange?
NRBO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 26.4 million | 4.9 million |
| June 30, 2023 | 29.2 million | 4.0 million |
| March 31, 2023 | 31.5 million | 11.0 million |
| Dec. 31, 2022 | 33.5 million | 11.8 million |
NRBO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -2.9 million | 172000 |
| June 30, 2023 | -2.0 million | 24000 |
| March 31, 2023 | -2.6 million | -74000 |
| Dec. 31, 2022 | -1.8 million | 218000 |
NRBO Net Income
No data available :(
NRBO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 25.8 million | - | 218000 |
| June 30, 2023 | 28.7 million | - | - |
| March 31, 2023 | 30.8 million | - | - |
| Dec. 31, 2022 | 33.4 million | - | - |
NRBO Shares Outstanding
NRBO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | 37000 | 2.3 million | 1.6 million | - |
| June 30, 2023 | - | 2.4 million | 1.4 million | - |
| March 31, 2023 | 4000 | 637000 | 1.9 million | - |
| Dec. 31, 2022 | - | 305000 | 1.9 million | - |
NRBO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | - | 1000 |
| June 30, 2023 | - | - |
| March 31, 2023 | - | 1000 |
| Dec. 31, 2022 | - | 1000 |
NRBO
Price: $2.36
52 week price:
Earnings Per Share: -5.01 USD
P/E Ratio: 13.28
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 985600
Market Capitalization: 21.6 million